Mon, October 1 – 10 Stories of The Day!
1 Oct, 2018 | 00:01h | UTC
See also: SAFER High Impact Strategies (free)
Related: WHO Global Status Report on Alcohol and Health 2018 (free report and commentaries)
2 – Guideline: Placenta Praevia and Placenta Accreta: Diagnosis and Management – British Journal of Obstetrics and Gynaecology (free)
3 – Guideline: Vasa Praevia: Diagnosis and Management – British Journal of Obstetrics and Gynaecology (free)
4 – Video: KHN Conversation on Overtreatment – Kaiser Health News (free)
Commentary: Changing Healthcare’s Culture of Overtreatment a Challenge – MedPage Today (free registration required)
Related KHN Series: Treatment Overkill (free articles)
5 – WCLC 2018: NELSON Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality – The ASCO Post (free)
Related: NELSON lung cancer study encourages widespread screening, Medicare reimbursement – Health Imaging (free) AND Second Large Study Shows That Lung Cancer Screening Works – Medscape (free registration required)
6 – Perspective: More Evidence That Nutrition Studies Don’t Always Add Up – The New York Times (10 articles per month are free)
7 – Podcast: #116 Geriatric Psychiatry: Sleep, Dementia, and Behavioral Disturbances – Curbsiders Internal Medicine Podcast (free)
Related Podcast: #115 Geriatric Depression – The Curbsiders Internal Medicine Podcast (free)
Commentary: Coenzyme Q10 reduces statin-induced myopathy symptoms – Univadis (free registration required)
Editorial: The Coming of Age of Drug-Susceptibility Testing for Tuberculosis (free)
Commentaries: Study heralds genetic era of TB drug susceptibility testing – CIDRAP (free) AND UK-led study marks shift towards genetic era in tackling TB – NIHR Oxford Biomedical Research Centre (free)
Related Guidelines: Clinical Practice Guidelines for Clostridium difficileInfection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) – Clinical Infectious Diseases (free) AND The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines – GUT (free)